Beijing-based neuromodulation medical device maker Leadinno Medical Valley reportedly raised over RMB 100 million (USD 14.4 million) in a Series A financing round led by Proxima Ventures and Med-Fine Capital. Other investors included TigerYeah Capital, Maron Investment, and Cowin Capital. The proceeds will be used for research and development (R&D) and manufacturing of spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS) products, expansion of the R&D team, and company operations.
Company Background and Focus
Founded in 2016, Leadinno is focused on the innovative technology R&D and promotion of products in the fields of pain management and neuromodulation. The company boasts the first domestically developed wireless portable implantable nerve stimulation product in China, highlighting its commitment to advancing medical device technology.-Fineline Info & Tech
